141 related articles for article (PubMed ID: 2011609)
21. Macrophages isolated from liver granulomas of murine Schistosoma mansoni synthesize predominantly TxA2 during the acute and chronic phases of infection.
Tripp CS; Needleman P; Kassab JT; Weinstock JV
J Immunol; 1988 May; 140(9):3140-3. PubMed ID: 3129511
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
Mayeux PR; Kadowitz PJ; McNamara DB
Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
[TBL] [Abstract][Full Text] [Related]
23. Substrate binding is the rate-limiting step in thromboxane synthase catalysis.
Wang LH; Tsai AL; Hsu PY
J Biol Chem; 2001 May; 276(18):14737-43. PubMed ID: 11297515
[TBL] [Abstract][Full Text] [Related]
24. Influence of chronic antigen exposure on the metabolism of PGH2 by microsomal preparations of airway and parenchymal tissues in the sheep.
Spannhake EW; Adams TL; Kleeberger SR
Prostaglandins; 1985 Dec; 30(6):1041-55. PubMed ID: 3911292
[TBL] [Abstract][Full Text] [Related]
25. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the involvement of the thromboxane synthase pathway in human natural cytotoxic cell activity.
Rola-Pleszczynski M; Gagnon L; Bolduc D; LeBreton G
J Immunol; 1985 Dec; 135(6):4114-9. PubMed ID: 4067311
[TBL] [Abstract][Full Text] [Related]
27. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
Anderson MW; Crutchley DJ; Tainer BE; Eling TE
Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis and pharmacological modulation of thromboxane in humans.
Patrono C
Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
[TBL] [Abstract][Full Text] [Related]
29. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
[TBL] [Abstract][Full Text] [Related]
30. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
31. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
32. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension.
Liel N; Nathan I; Yermiyahu T; Zolotov Z; Lieberman JR; Dvilansky A; Halushka PV
Thromb Res; 1993 May; 70(3):205-10. PubMed ID: 8327985
[TBL] [Abstract][Full Text] [Related]
33. A concept for the mechanism of prostacyclin and thromboxane A2 biosynthesis.
Ullrich V; Hecker M
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():95-101. PubMed ID: 2144703
[No Abstract] [Full Text] [Related]
34. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
Mais DE; Saussy DL; Magee DE; Williams CM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
[No Abstract] [Full Text] [Related]
35. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Mais DE; Liel N; Halushka PV
Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
[TBL] [Abstract][Full Text] [Related]
36. Thromboxane synthesis and action within the kidney.
Remuzzi G; FitzGerald GA; Patrono C
Kidney Int; 1992 Jun; 41(6):1483-93. PubMed ID: 1501404
[TBL] [Abstract][Full Text] [Related]
37. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
Fonlupt P; Croset M; Lagarde M
Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628
[TBL] [Abstract][Full Text] [Related]
38. Mechanism-based inactivation of thromboxane A2 synthase.
Fitzpatrick FA; Jones D; Winitz S; Fish HT
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():161-3. PubMed ID: 1825535
[No Abstract] [Full Text] [Related]
39. An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages.
Kuhn DC; Stauffer JL; Gaydos LJ; Lacey SL; Demers LM
Prostaglandins; 1993 Sep; 46(3):195-205. PubMed ID: 8234828
[TBL] [Abstract][Full Text] [Related]
40. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
